Alembic Pharmaceuticals

quarterly
yearly
ParticularsMar '24Jun '24Sep '24Dec '24Mar '25
Revenue1,4821,4791,5961,4221,584
Expenses1,2661,2661,4091,3181,492
EBITDA295.41294.57275.55195.29183.87
EBIT226.29225.89218.30125.60115.27
Profit Before Tax216.16213.20200.02103.8191.56
Net Profit201.87176.19165.7885.8175.34
Financial Ratios
Operating Profit Margin20.03%19.96%18.25%13.89%11.71%
Net Profit Margin13.69%11.94%9.81%6.10%4.80%
Earning Per Share (Diluted)10.278.968.434.373.83
Dividends Per Share0.000.000.000.000.00